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Retroviral restriction is a complex phenomenon that, despite remarkable recent progress, is far
from being well understood. In this Preview, we introduce an insightful study by Yang et al. that
represents the first attempt to identify the global determinants of retroviral repression in pluripotent
mammalian cells.To protect their genomic integrity, animals
control retroviral infections by establish-
ing heritable epigenetic silencing of the
integrated provirus in early embryonic
development. In mouse embryonic stem
cells (ESCs), KAP1 (Trim28) is targeted
to newly integrated Moloney murine leu-
kemia virus (MMLV) by the Krueppel-
associated box (KRAB) zinc finger protein
ZFP809. KAP1, in turn, recruits histone-
modifying enzymes, including the histone
methyl transferase SETDB1 (ESET), that
deposit repressive histone 3 lysine 9
trimethylation (H3K9me3) marks at the
provirus (Figure 1) (Matsui et al., 2010;
Rowe et al., 2010; Wolf and Goff, 2009).
The KRAB/KAP1 system also represses
endogenous retroviruses (ERVs), which
are potentially hazardous remnants of
retroviral germline infections (Matsui
et al., 2010; Rowe et al., 2010; Wolf
et al., 2015). Additionally, several cofac-
tors of the KRAB/KAP1 system, but also
KAP1-independent retroviral repression
pathways, have been identified over the
last few years. Indeed, the abundance
and sequence diversity of exogenous
and endogenous retroviruses likely droveevolution of complex and partially redun-
dant repression mechanisms that keep
these elements under control. Moreover,
some ERVs have been adapted as
new regulatory elements and, in some
cases, have re-wired entire transcriptional
networks (Macfarlan et al., 2012). Retro-
viral repression mechanisms might
therefore also regulate transcription of
cellular genes. Despite recent progress
in the field, deciphering the complexity
and interconnectivity of retroviral repres-
sion pathways and networks remains
an outstanding problem of mammalian
genome biology. The Resource article
by Yang et al. (2015) performs a
genome-wide small interfering RNA
(siRNA) knockdown screen in a first
attempt to determine in a global manner
the components of retroviral repression
machinery in mammalian pluripotent
cells.
The siRNA screen was performed using
a MMLV reporter that is repressed by
ZFP809/KAP1 and is therefore primarily
aimed at identifying cofactors acting up-
and downstream of the KRAB/KAP1 sys-
tem, but also at potentially overlappingKAP1-independent repression pathways.
Apart from previously known factors,
including ZFP809, KAP1, and SETDB1,
hundreds of new repression candidates
were identified. As expected,many candi-
dates are associated with chromatin
modification, DNA methylation, and regu-
lation of transcription. Additionally, the
screen identified genes involved in protein
sumoylation, DNA repair, and DNA repli-
cation and even factors located outside
of the nucleus (e.g., plasma membrane,
cytoskeletal, and organelle proteins).
These findings highlight the complexity
of retroviral restriction networks in
mammalian cells, although many of these
factors may not primarily, specifically,
and/or directly repress retroviruses.
Without a doubt, the provided candidate
list is a potentially valuable resource for
future studies that may address how
these factors mediate retroviral restriction
and ultimately help us to better under-
stand how epigenetic silencing of retro-
viruses is established, maintained, and
inherited during development.
Two of the newly identified repression
mechanisms are subsequently analyzed
Figure 1. SUMO2/CAF-1-Assisted Retroviral Silencing
Simplified models of SUMO2/CAF-1-assisted retroviral silencing are depicted. (Top) The MMLV provirus
and some endogenous retroviruses are targeted by various KRAB zinc finger proteins (KRAB-ZFPs) that
recruit the KAP1 corepressor. KAP1, among other functions, recruits SETDB1, which deposits the
repressive H3K9me3 mark at histone H3. HP1, a reader of the H3K9me3 mark, may recruit CAF-1.
Alternatively, SETDB1, which immunoprecipitates with CAF-1, might be involved in CAF-1 recruitment
to the proviral DNA. In concert with other factors, CAF-1 delivers a H3-H4 dimer onto the retroviral
DNA during replication to maintain the repressive mark. (Bottom) MERVL elements are not repressed
by the KRAB/KAP1/SETDB1 complex and lack the H3K9me3 mark. Instead, MERVL ERVs are repressed
by the H3K4 lysine demethylase KDM1A and histone deacetylases, such as HDAC2, which both remove
histone modifications associated with open chromatin and transcription. CAF-1 knockdown results
in epigenetic changes and retroviral de-repression, but also to the activation of MERVL-regulated
2C genes. This ultimately facilitates the transition of ESCs to a more epigenetically pliable state, similar
to 2C embryos.in detail to validate the significance of the
screen: KAP1 sumoylation and chromatin
assembly at proviruses. Yang et al. show
that KAP1 sumoylation by SUMO2 is
required for KAP1 recruitment to the
MMLV provirus and ERVs and thus for
epigenetic silencing of these elements.
This supports previous findings that su-
moylation of KAP1 by SUMO2
is essential for forming a stable KRAB/
KAP1/SETDB1 repression complex (Iva-
nov et al., 2007). CHAF1A, one of the top
hits in the screen, is the core component
of the chromatin assembly factor-1
(CAF-1). CAF-1 depletion impairs repres-
sion of newly integrated proviruses and
also promotes reactivation of several
ERV families, many of which are bound
by both CAF-1 and KAP1 (Yang et al.,
2015). Although this implies that CAF-1
is a component of the KRAB/KAP1
silencing system, SUMO2 knockdown,
which results in KAP1 loss at the MMLV
provirus, does not disrupt CAF-1 binding(Yang et al., 2015). This indirectly indi-
cates that CAF-1 recruitment to retro-
viruses is independent of KAP1 binding.
The question remains: how is CAF-1
targeted to retroviral elements? One
possibility is that CAF-1 re-assembles
histones at repressed retroviral elements
after DNA replication and thus aids to
maintain heterochromatin marks, as pre-
viously suggested (Yu et al., 2015). In
this model, free histone H3, mono-meth-
ylated by SETDB1, is incorporated into
newly synthesized heterochromatic DNA
by CAF-1 and is further methylated to
form stable heterochromatin on the newly
synthesized strand via heterochromatin
protein 1 (HP1), which binds to the
H3K9me3 mark (Yu et al., 2015). CAF-1
immunoprecipitates with both SETDB1
and HP1, possibly explaining its localiza-
tion at retroviral elements (Figure 1)
(Yang et al., 2015; Yu et al., 2015). Howev-
er, it has yet to be determined whether
CAF-1 localization at KAP1-controlledCell 163, SERVs is indeed replication dependent
and whether the chromatin assembly
function and/or the PCNA-HP1 interact-
ing function of CAF-1 is required for ERV
silencing. Furthermore, it remains open
whether CAF-1 localizes exclusively at
ERV-associated heterochromatin or also
at non-viral genes that are repressed by
KRAB/KAP1, for example, at imprinted
genes. Nevertheless, the findings pro-
vided by Yang et al. strongly support a
role for CAF-1 in the establishment and/
or maintenance of heterochromatin at
ERVs after DNA replication.
Interestingly, CAF-1 is also recruited
to ERVs that are not bound by KAP1,
SETDB1, or H3K9me3—especially class
III ERVs, which consist primarily of
MERVL elements (Figure 1). These ele-
ments are among the ERVs with the high-
est reactivation levels in CAF-1-depleted
cells (Yang et al., 2015), an observation
supported by a recent report (Ishiuchi
et al., 2015). This indicates that CAF-1
may target and repress different ERV
classes by entirely different mechanisms.
Previously, it has been shown thatMERVL
repression by CAF-1 requires the chro-
matin-assembly activity of CAF-1, but
not its functional interaction with HP1
and PCNA (Ishiuchi et al., 2015). More-
over, growth arrest of CAF-1 knockdown
ESCs at G1-S preventedMERVL reactiva-
tion, indicating that CAF-1 acts to repress
MERVL elements during or after DNA
replication (Ishiuchi et al., 2015). Yang
et al. also show that KDM1A (LSD1),
which physically interacts with CAF-1,
is strongly enriched at CAF-1-bound
MERVL elements (Yang et al., 2015).
KDM1A represses MERVL elements in
ESCs (Macfarlan et al., 2011), but
KDM1A binding at MERVL ERVs has not
been previously demonstrated. However,
it remains open how CAF-1 and KDM1A
are targeted to these elements.
Depletion of KDM1A in ESCs leads
to de-repression of MERVL transcripts
and MERVL-associated genes, but also
to an increased number of spontane-
ously arising cells resembling two-cell-
stage embryos (2C-like cells) within
the ESC population (Macfarlan et al.,
2012). Interestingly, CAF-1 knockdown
ESCs exhibited similar phenotypes
(Ishiuchi et al., 2015). Moreover, the
nuclei of 2C-like cells originating from
CAF-1 knockdown ESCs are alsoeptember 24, 2015 ª2015 Elsevier Inc. 31
shown to lack chromocenters and are
more efficiently reprogrammed by nu-
clear transfer into enucleated oocytes
(Ishiuchi et al., 2015), supporting the
important link between CAF-1/KDM1A-
mediated retroviral repression and
cellular epigenetic potential in early
development.
Altogether, Yang et al. provide a
valuable source for retroviral repression
candidates using a genome-wide
siRNA knockdown screen. Importantly,
several of the newly identified factors
are confirmed to function in pathways
that have not been directly associated
with retroviral repression before. This
validation strongly supports that the
screen identified bona fide candidates,
whose further investigation will not
only deepen our understanding of the
complex retroviral restriction networks,32 Cell 163, September 24, 2015 ª2015 Elsebut also reveal new regulatory mecha-
nisms in retrovirus-derived transcrip-
tional networks.REFERENCES
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